{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2023,5,19]],"date-time":"2023-05-19T04:47:28Z","timestamp":1684471648842},"reference-count":9,"publisher":"Springer Science and Business Media LLC","issue":"12","license":[{"start":{"date-parts":[[2013,10,4]],"date-time":"2013-10-04T00:00:00Z","timestamp":1380844800000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Eye"],"published-print":{"date-parts":[[2013,12]]},"DOI":"10.1038\/eye.2013.216","type":"journal-article","created":{"date-parts":[[2013,10,4]],"date-time":"2013-10-04T15:05:20Z","timestamp":1380899120000},"page":"1422-1423","source":"Crossref","is-referenced-by-count":1,"title":["Reply: \u2018Central retinal artery occlusion and cerebral stroke\u2019"],"prefix":"10.1038","volume":"27","author":[{"given":"A W","family":"Lee","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"C S","family":"Chen","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"S","family":"Cugati","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"D","family":"Varma","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2013,10,4]]},"reference":[{"key":"BFeye2013216_CR1","doi-asserted-by":"publisher","first-page":"1422","DOI":"10.1038\/eye.2013.219","volume":"27","author":"D McLeod","year":"2013","unstructured":"McLeod D . Central retinal artery occlusion and cerebral stroke. Eye 2013; 27: 1422.","journal-title":"Eye"},{"key":"BFeye2013216_CR2","doi-asserted-by":"publisher","first-page":"688","DOI":"10.1038\/eye.2013.25","volume":"27","author":"DD Varma","year":"2013","unstructured":"Varma DD, Cugati S, Lee AW, Chen CS . A review of central retinal artery occlusion: clinical presentation and management. Eye 2013; 27: 688\u2013697.","journal-title":"Eye"},{"key":"BFeye2013216_CR3","doi-asserted-by":"publisher","first-page":"2276","DOI":"10.1161\/STROKEAHA.108.192218","volume":"40","author":"JD Easton","year":"2009","unstructured":"Easton JD, Saver JL, Albers GW, Alberts MJ, Chaturvedi S, Feldmann E et al. Definition and Evaluation of Transient Ischemic Attack: A Scientific Statement for Healthcare Professionals From the American Heart Association\/American Stroke Association Stroke Council; Council on Cardiovascular Surgery and Anesthesia; Council on Cardiovascular Radiology and Intervention; Council on Cardiovascular Nursing; and the Interdisciplinary Council on Peripheral Vascular Disease: the American Academy of Neurology affirms the value of this statement as an educational tool for neurologists. Stroke 2009; 40: 2276\u20132293.","journal-title":"Stroke"},{"key":"BFeye2013216_CR4","doi-asserted-by":"publisher","first-page":"51","DOI":"10.1161\/01.STR.8.1.51","volume":"8","author":"J Astrup","year":"1977","unstructured":"Astrup J, Symon L, Branston NM, Lassen NA . Cortical evoked potential and extracellular K+ and H+ levels at critical levels of brain ischemia. Stroke 1977; 8: 51\u201357.","journal-title":"Stroke"},{"key":"BFeye2013216_CR5","doi-asserted-by":"publisher","first-page":"1317","DOI":"10.1056\/NEJMoa0804656","volume":"359","author":"W Hacke","year":"2008","unstructured":"Hacke W, Kaste M, Bluhmki E, Brozman M, D\u00e1valos A, Guidetti D et al. Thrombolysis with Alteplase 3 to 4.5 Hours after Acute Ischemic Stroke. N Engl J Med 2008; 359: 1317\u20131329.","journal-title":"N Engl J Med"},{"key":"BFeye2013216_CR6","doi-asserted-by":"publisher","first-page":"2352","DOI":"10.1016\/S0140-6736(12)60768-5","volume":"379","author":"P Sandercock","year":"2012","unstructured":"Sandercock P, Wardlaw JM, Lindley RI, Dennis M, Cohen G, Murray G et al. The benefits and harms of intravenous thrombolysis with recombinant tissue plasminogen activator within 6h of acute ischaemic stroke (the third international stroke trial [IST-3]): a randomised controlled trial. Lancet 2012; 379: 2352\u20132363.","journal-title":"Lancet"},{"key":"BFeye2013216_CR7","doi-asserted-by":"publisher","first-page":"950","DOI":"10.1007\/s00417-005-0140-2","volume":"244","author":"N Feltgen","year":"2006","unstructured":"Feltgen N, Neubauer A, Jurklies B, Schmoor C, Schmidt D, Wanke J et al. Mutlicenter study of the European Assessment Group for Lysis in the Eye (EAGLE) for the treatment of central retinal artery occlusio: design issues and implications. EAGLE study report no. 1. Graefes Arch Clin Exp Ophthalmol 2006; 244: 950\u2013956.","journal-title":"Graefes Arch Clin Exp Ophthalmol"},{"key":"BFeye2013216_CR8","doi-asserted-by":"publisher","first-page":"2229","DOI":"10.1161\/STROKEAHA.111.613653","volume":"42","author":"CS Chen","year":"2011","unstructured":"Chen CS, Lee AW, Campbell B, Lee T, Paine M, Fraser C et al. Efficacy of intravenous tissue-type plasminogen activator in central retinal artery occlusion: report from a randomized, controlled trial. Stroke 2011; 42: 2229\u20132234.","journal-title":"Stroke"},{"key":"BFeye2013216_CR9","doi-asserted-by":"publisher","first-page":"723","DOI":"10.1016\/S0014-4835(03)00214-8","volume":"78","author":"SS Hayreh","year":"2004","unstructured":"Hayreh SS, Zimmerman MB, Kimura A, Sanon A . Central retinal artery occlusion. Retinal survival time. Exp Eye Res 2004; 78: 723\u2013736.","journal-title":"Exp Eye Res"}],"container-title":["Eye"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/www.nature.com\/articles\/eye2013216.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/www.nature.com\/articles\/eye2013216","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/www.nature.com\/articles\/eye2013216.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,5,18]],"date-time":"2023-05-18T17:19:45Z","timestamp":1684430385000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/eye2013216"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2013,10,4]]},"references-count":9,"journal-issue":{"issue":"12","published-print":{"date-parts":[[2013,12]]}},"alternative-id":["BFeye2013216"],"URL":"https:\/\/doi.org\/10.1038\/eye.2013.216","relation":{},"ISSN":["0950-222X","1476-5454"],"issn-type":[{"value":"0950-222X","type":"print"},{"value":"1476-5454","type":"electronic"}],"subject":[],"published":{"date-parts":[[2013,10,4]]}}}